Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,125,100
+$184,487 QoQ
Shares Held
12,305
+2.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,981
of 4,676 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Engines Advisors L.L.C. holds $32,908,375 across 9 Drug Manufacturers - General names. JNJ ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
83,818 | $21,091,961 | |
| 2 | LLY |
ELI LILLY & Co
|
2,700 | $3,238,461 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
12,305 | $3,125,100 | |
| 4 | AMGN |
Amgen Inc
|
5,295 | $1,917,425 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,510 | $1,093,535 | |
| 6 | NVS |
Novartis AG
|
6,697 | $1,049,553 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,130 | $526,070 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,619 | $457,224 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,125,100 | 12,305 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,940,613 | 12,030 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,369,991 | 11,452 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,322,385 | 12,525 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,368,083 | 15,503 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,498,364 | 9,035 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,542,516 | 10,666 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,511,371 | 9,326 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,154,956 | 7,902 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,236,887 | 7,819 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,460,189 | 9,316 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,316,243 | 8,451 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,478,755 | 8,934 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $801,040 | 5,168 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $989,946 | 5,604 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,142,866 | 6,996 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,305,408 | 7,354 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,276,942 | 7,205 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $936,437 | 5,474 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,058,148 | 6,552 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,146,096 | 6,957 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,247,580 | 7,591 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $935,465 | 5,944 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $732,191 | 4,918 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $459,156 | 3,265 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||